Edesa Biotech, Inc. - FORM 10-K - EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - December 7, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Edesa Biotech, Inc.edsa_ex312.htm
10-K - ANNUAL REPORT - Edesa Biotech, Inc.edsa_10k.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Edesa Biotech, Inc.edsa_ex321.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Edesa Biotech, Inc.edsa_ex311.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - Edesa Biotech, Inc.edsa_ex231.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - Edesa Biotech, Inc.edsa_ex21.htm
EX-10.21 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND KATHI NIFFENEGGER - Edesa Biotech, Inc.edsa_ex1021.htm
Exhibit 32.2
 
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
 
In connection with the Annual Report of Edesa Biotech, Inc. (the Company) on Form 10-K for the year ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Kathi Niffenegger, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
  
1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: December 7, 2020
By: /s/ Kathi Niffenegger
  
Kathi Niffenegger
 
Chief Financial Officer
 
(Principal Financial Officer)
 
 
 

Edesa Biotech, Inc. Reports